Skip to Main Content
Table 1—

Veterans receiving oral glycemic control agents as monotherapy or combination therapy in the VA in FY2000

AgentSingle oral agents
>1 Oral agent
Total
Without insulinWith insulinTotalWithout insulinWith insulinTotal
Sulfonylurea (first generation) 3,170(0.8) 234(0.1) 3,404(0.8) 1,806(0.4) 222(0.1) 2,028(0.5) 5,432(1.3) 
 Average cost/patient* 33.08 36.56 33.32     
Sulfonylurea (second generation) 166,121(40.2) 21,049(5.1) 187,170(45.3) 122,061(29.5) 22,280(5.4) 144,341(34.9) 331,511(80.2) 
 Average cost/patient 19.78 34.39 21.42     
Metformin 38,220(9.2) 26,443(6.4) 64,663(15.6) 118,082(28.6) 22,952(5.6) 141,034(34.1) 205,697(49.8) 
 Average cost/patient 173.86 213.14 189.93     
α-Glucosidase inhibitors 495(0.1) 561(0.1) 1,056(0.3) 4,928(1.2) 1,987(0.5) 6,915(1.7) 7,971(1.9) 
 Average cost/patient 135.62 145.90 141.08     
Repaglinide 83(0.0) 29(0.0) 112(0.0) 236(0.1) 94(0.0) 330(0.1) 442(0.1) 
 Average cost/patient 250.16 288.79 260.16     
Thiazolidinediones 1,198(0.3) 5,415(1.3) 6,613(1.6) 12,587(3.0) 7,279(1.8) 19,866(4.8) 26,479(6.4) 
 Average cost/patient 343.31 537.78 502.55     
AgentSingle oral agents
>1 Oral agent
Total
Without insulinWith insulinTotalWithout insulinWith insulinTotal
Sulfonylurea (first generation) 3,170(0.8) 234(0.1) 3,404(0.8) 1,806(0.4) 222(0.1) 2,028(0.5) 5,432(1.3) 
 Average cost/patient* 33.08 36.56 33.32     
Sulfonylurea (second generation) 166,121(40.2) 21,049(5.1) 187,170(45.3) 122,061(29.5) 22,280(5.4) 144,341(34.9) 331,511(80.2) 
 Average cost/patient 19.78 34.39 21.42     
Metformin 38,220(9.2) 26,443(6.4) 64,663(15.6) 118,082(28.6) 22,952(5.6) 141,034(34.1) 205,697(49.8) 
 Average cost/patient 173.86 213.14 189.93     
α-Glucosidase inhibitors 495(0.1) 561(0.1) 1,056(0.3) 4,928(1.2) 1,987(0.5) 6,915(1.7) 7,971(1.9) 
 Average cost/patient 135.62 145.90 141.08     
Repaglinide 83(0.0) 29(0.0) 112(0.0) 236(0.1) 94(0.0) 330(0.1) 442(0.1) 
 Average cost/patient 250.16 288.79 260.16     
Thiazolidinediones 1,198(0.3) 5,415(1.3) 6,613(1.6) 12,587(3.0) 7,279(1.8) 19,866(4.8) 26,479(6.4) 
 Average cost/patient 343.31 537.78 502.55     

Data are n (%) of all patients receiving any oral agent(s).

*

Cost for specified oral agent(s).

Close Modal

or Create an Account

Close Modal
Close Modal